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Abstract 
The use of various oligonucleotide (ON) syntheses and post-synthetic strategies for targeted 
chemical modification enables improving their efficacy as potent modulators of gene expression 
levels in eukaryotic cells. However, the search still continues for new approaches designed for 
increasing internalization, lysosomal escape, and tissue specific delivery of ON. In this review we 
emphasized all aspects related to the synthesis and properties of ON derivatives carrying 
multifluorinated (MF) groups. These MF groups have unique physico-chemical properties because of 
their simultaneous hydrophobicity and lipophobicity. Such unusual combination of properties 
results in the overall modification of ON mode of interaction with the cells and making 
multi-fluorination highly relevant to the goal of improving potency of ON as components of new 
therapies. The accumulated evidence so far is pointing to high potential of ON probes, RNAi 
components and ON imaging beacons carrying single or multiple MF groups for improving the 
stability, specificity of interaction with biological targets and delivery of ONs in vitro and potentially 
in vivo. 
Key words: oligonucleotide, perfluorinated, drug delivery, sensor, fluorescence, magnetic resonance 
spectroscopy 
Introduction 
Chemical modification of oligonucleotides (ON) 
is universally recognized as the most facile strategy 
for improving their ability to alter the levels of gene 
expression in vitro and in vivo [1]. In this regard, 
unique properties of fluorine continue to attract 
attention of multiple research groups which 
investigated novel synthetic materials for biomedical 
applications [2]. In the past the introduction of 
2’-fluorine atoms into the composition of ON during 
the synthesis was successfully used for improving 
stability and kinetic properties of synthetic 
oligoribonucleotide-based ribozymes [3]. Further 
increase of fluorine incorporation into the backbone of 
ON analogs was also considered. Modification of the 
backbone of peptide nucleic acids (PNA) with only 
two fluorines per three nucleobases has been shown 
to change the properties of the resultant PNA so 
dramatically that their ability to cross cellular 
membranes showed a marked improvement [4]. 
Subsequently, multifluorinated (MF) groups that have 
an advantage of high local density of fluorine atoms 
were also investigated as potential ON modifiers. 
Unlike more traditional 2’- fluorination of nucleosides 
MF were relatively recently introduced as 
components of new materials based on chemically 
modified nucleic acids [5-7]. Such chemical 
modification of nucleic acids does not require 
extensive substitution of all backbone components 
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and usually includes a single point chemical 
modification [8]. The resultant multifluorinated 
oligonucleotides (MF-ON) embody a combination of 
two very different essential parts: 1) multifluorinated 
component(s), which are simultaneously highly 
hydrophobic and lipophobic (repelling hydrocarbons) 
giving MF-ON a tendency to engage in self-assembly 
into various supramolecular structures; 2) relatively 
hydrophilic and water- soluble component (i.e. ON or 
ON analog) responsible for specific interactions with 
target nucleic acids or proteins. In general, synthetic 
strategies and microenvironment play crucial roles 
and in multiple aspects they guide the assembly of 
oligonucleotide components in various 
supramolecular structures [9]. The properties of these 
structures as well as MF-ON building blocks can 
potentially assist in designing oligonucleotide 
conjugates with diverse architecture, fluorine-based 
NMR spectroscopic/imaging tags and improved 
delivery in vitro and in vivo resulting in an enhanced 
therapeutic potential [8]. In this review we set forth to 
address various aspects of synthesis and properties of 
MF-ON modified with fluorocarbon-containing 
(perfluoroalkyl) moieties such as covalently linked 
tags and multiple “tails” since the goal of maximizing 
the local density of fluorine atoms within the 
molecule is important for intracellular delivery and 
NMR spectroscopy due to specific fluorine nuclear 
spin relaxation properties. 
Synthesis of ON containing MF moieties 
The great majority of fluoro-modified 
oligonucleotides reported so far were obtained by 
using chemical synthesis including: a) standard solid 
phase ON synthesis requiring the use of specialty 
synthons for introducing perfluoroalkyl moieties; b) 
post-synthetic conjugation of fluorocarbon-containing 
groups by using premade oligonucleotides containing 
suitable reactive or activatable moieties. 
Incorporation of MF groups in MF-ON 
composition during synthesis 
In the majority of cases MF groups were 
included into ON composition as ON termini 
modifiers. Those reactions involve the use synthons or 
commercially available multifluorine-containing 
reagents for standard solid phase synthesis. Several 
examples of various MF-synthons were suggested so 
far, which are combined in Table 1 of this review for 
convenience. For example, to study intracellular 
transport of modified ONs a commercially available 
synthon Ia was used for the synthesis of a 21-base 
long phosphorothioate-bond stabilized ONs 
5’-derivatives. The resultant MF-ON contained 
perfluorooctylpropyl (CF3(CF2)7(CH2)3) residues as 
well as aminoethyldiethylene glycol linkers at various 
internucleoside positions [10](see structure MF-ON 
1a, Table 2). Amino linkers were used for conjugating 
various organic fluorophores that enables sensitive 
detection of MF-ON distribution within the cells in 
vitro.  
The synthesis of various fluoro-modified 
phosphoroamidites is relatively straightforward and 
can be accomplished by reacting 2-cyanoethyl 
chlorodiisopropylphosphoramidite with correspond-
ing alcohols provided the latter are commercially 
available. The examples include 2-cyanoethyl 
(1H,1H,2H,2H-perlfuorodecyl)diisopropylphosphora
midite (Table 1, synthon Ib) [11] or 2-cyanoethyl 
(1H,1H,2H,2H-perlfuorooctyl)diisopropylphosphora
midite (Ic) that were used in the past for the synthesis 
of the following end-modified MF-ONs [12]:  
C6F13CH2CH2pATCCTTATCAAT (shown in 
Table 2, MF-ON 2) C8F17CH2CH2[p(CH2CH2O)6]3pTG 
CAGATAGATAGCAG, C8F17CH2CH2[p(CH2CH2O)6-
]3pCATCATGAATTCCATAAGCTTCATGGATCCA
T (Table 2, MF-ON 3).  
Nucleoside phosphoramidites with tert-butyl- 
phenyl-1H,1H,2H,2H-perfluorodecyloxysilyl groups 
(synthon II, Table 1) were previously used to 
synthesize fluorous-tagged oligonucleotides, as 
5-mer, 10-mer, 13-mer, 17-mer, and 19-mer long 
MF-ONs [13]. This synthon enabled synthesis of 
oligonucleotides that could be easily separated from 
failure sequences and reportedly resulted in high 
recovery of the end products. To improve efficiency of 
MF-ON isolation from reaction mixtures 5’-O- 
[4,4’-dimethoxy-4’’-(1H,1H,2H,2H-perfluorodecyl)trit
yl] group was proposed as an end-modifier instead of 
a standard DMTr-group. For the synthesis of 
30-100-mer oligonucleotides (please see the structure 
of 30-mer MF-ON, Table 2, MF-ON 4) specially 
designed synthons were used (e.g. synthon III, Table 
1) [14]. This universal approach was suggested as a 
strategy for isolating the most or all of the full-length 
sequences with resultant failure sequence-free ONs.  
Furthermore, perfluoroalkyl groups could be 
separated from ON termini by various spacers that 
were either hydrophilic, or hydrophobic. Importantly, 
the end products (i.e. MF-ON with fluorinated-groups 
at the 5’- terminus) can be easily separated from other 
components of reaction mixture due to the properties 
of linked MF group that results in very large 
differences in elution times. For example, ON carrying 
a single heptadecafluoroundecylcarbamoylnonyl 
group is eluted with a delay of 4-5 min compared to a 
standard DMTr-O-protected ON with identical 
nucleotide sequence on a standard C18 reversed 
phase HPLC column due to unique interactions 
between MF residues that potentially result in 
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non-covalent supramolecular associates of fluorinated 
ON [10]. Other synthons applied in the past for 
MF-modified ON synthesis (Table 1, IV, V) and 
especially those containing branched structures, 
require more elaborate and time-consuming 
syntheses. For example, the synthesis of synthon IV 
(Table 1) was accomplished [15] according to Scheme 
1. 
 
 
Scheme 1. Synthesis of synthon IV from 4-aminophenol and heptadecafluoroundecyl iodide with further O-phosphitylation of the corresponding alkylation product. 
Table 1. Chemical structure and applications of nucleoside synthons used for synthesis of MF-ON. 
Abbreviation 
 
R= 
Reference Use in PFO synthesis 
Ia 
 
 
[10] 
 
synthesis of 5’-modified ON  
Ib 
 
 
[11] 
Ic 
 
[12] 
II 
 
[13] synthesis of 5’-modified ON  
Theranostics 2020, Vol. 10, Issue 3 
 
 
http://www.thno.org 
1394 
III 
 
[14] Fluorous affinity purification of ON 
IV 
 
[15] Synthesis of 5’-modified ON 
V 
 
[16] Introduction of C8F17-tails into ON 
 
 
 
VI 
 
[17] Introduction of  
5-MF-2’-deoxyuridine into any position of ON chain 
VIIa 
 
 
[18] Introduction of 5-MF-2’-deoxyuridine into any 
position of ON chain  
 
 
VIIb 
VIIIa 
 
 
[19] Introduction of “F-bases” into any position of ON 
chain 
VIIIb 
 
 
[20] Synthesis of ON containing 3,5-bis(trifluoromethyl) 
benzene  
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VIIIc 
 
[21] ON with 3,5-bis (trifluoromethyl) benzene in 
5’-position  
IX 
 
[22] 5’-bromo-5’-deoxythymidine on 5’- end of ON for 
subsequent synthesis of azido derivatives 
X 
 
[10] ON with activated group on 5’-end for post synthetic 
modification with perfluorinated amines 
XI 
 
[23] Enzymatic primer extension synthesis of ONs 
 
 
 
Scheme 2. The synthesis of synthon V starting from converting a perfluorinated alcohol into corresponding triflate followed by heating in the presence of diethanolamine, 
monoprotection of the first hydroxyl group and phosphitylation of the second. 
 
As a result by using synthon IV (Table 1) [15] 
oligonucleotides carrying pyrene as a fluorescent tag 
(PY) and branched MF groups such as MF-py-T15 (5), 
MF-TTTCCCAGCCCTC-FAM, MF-T15-TAMPA 
(Table 2, MF-ON 5), MF-py-T30, MF-T45 and others 
were obtained. Due to specifics of chemical structure, 
these synthons could be used either for single-step 
linking (Ia-c, II-IV, Table 1) of MF groups to 
oligonucleotides, or for multiple attachment (i.e. as 
multiple “tails” linked in a row, synthon V Table 1). 
The synthesis of synthon V (Table 1) was 
accomplished [16] by following Scheme 2.  
The authors reported successful synthesis of 
ONs bearing MF groups at the termini as well as ON 
containing MF groups within the nucleotide sequence 
(see also MF-ON 6a-h, Table 2): XnTTTTTCA 
GTTGACCATATA, TTTTTCAGTXnTGACCATATA, 
TTTTTCXAGTTGACXCATATA, TATATGGTCAA 
CTGAAAAAXn, TATATGXGTCAACTXGAAAAA, 
TATATGGTCAXnACTGAAAAA, GUCAUCACAC 
UGAAUACCAAUX, where X is a MF, and n=1-10 in 
the case of ON’s termini or n= 1-2 if MF groups were 
positioned within the sequence of the ON. The 
synthesis of ON with MF “segment” linked to 
heterocyclic moiety was accomplished by using 
standard solid phase oligonucleotide synthesis and 
synthons containing MF tert-butyl- or perfluoroalkyl- 
groups (examples VI, VIIa-b, Table 1).  
The synthesis of synthon VI (Table 1) was 
accomplished [17] by following the Scheme 3.  
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The synthon in Scheme 3 is often considered to 
be the first example of a precursor specifically 
designed for conjugating perfluorinated tert-butyl 
groups to nucleic acids. In particular, oligonucleotides 
containing modified 2’-deoxyuridine were obtained 
for synthesis of NMR reporter ONs, i.e. 
d(CACGA*UGCGAGGTC) (Table 2, MF-ON 7) and 
d(G*UGCGCA), where *U is modified residue. The 
synthesis of synthons VIIa and VIIb (Table 1) was 
accomplished [17] by following the Scheme 4. 
 
 
 
Scheme 3. Synthesis of synthon VI using Sonogashira coupling reaction starting from 5-iodo-2’-deoxyuridine that included two standard synthetic steps: 1) 5’-O-tritylation, 2) 
3’-O-phosphitylation. 
 
 
Scheme 4. Synthesis of synthons VIIa and VIIb involving palladium-catalyzed coupling reaction between the 5-iodocytosine with organozinc reagents followed by two standard 
synthetic steps: 5’-O-tritylation and 3’-O-phosphitylation. 
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The separation of the modified ON products 
(e.g. MF-ON 8, Table 2) from nonfluorinated ON was 
feasible after incorporating MF-alkylcytosine. The 
incorporation of 5-C2F5 required careful elution while 
compounds with larger 5-C6F13 and 5-C8F17 residues 
could be easily separated from non-fluorous 
components. Structurally similar synthons VIIIa-c 
containing 3,5-bis(trifluoromethyl)phenyl groups 
instead of MF-alkyl moieties were used to obtain 
modified oligonucleotides. The synthesis of synthons 
VIIIa (Table 1) was accomplished [18] by following 
the Scheme 5. 
By introducing of “F base” into molecular 
beacons the spontaneous formation of sticky stem 
elements was intended to yield the assembly of a 
“self-complementary” structure. The formation of 
such structure was assumed to be a result of F-F 
interactions of stacking flat aromatic groups. Several 
MF-ON types were synthesized containing multiple 
“F bases” that had a general formula of: 
fluorophore1-[F]n[TCTAAATCACTATGGTCGC][F]n-
fluorophore2, where n=2-7 and fluorophores formed 
an interacting pair of energy donor and acceptor 
engaged in Förster resonance energy transfer [19]. As 
an example of such design, the structure of 
FAM-FFFFFFTCTAAATCACTATGGTCGCFFFFFF- 
Dabcyl carrying six F-base pairs included in the 
stabilizing “stem” is shown in Table 2 (compound 9). 
Two related synthons VIIIb and VIIIc (Table 1) [20, 
21] were obtained by using identical synthetic steps 
and were used for the synthesis of specially designed 
probes for 19F NMR spectroscopy (Table 2, compound 
10a and 10b) with 2-(hydroxymethyl)-2-[3,5-bis 
(trifluoromethyl)benzamido]ethyl- or 3,5-bis(trifluoro 
metyl)benzyl-groups linked to the 5’-phosphate.  
The second approach previously used for the 
synthesis of MF-ONs included the introduction of 
monomeric units that allowed incorporating reactive 
groups into the oligonucleotide chain for subsequent 
conjugation with fluorinated compounds. 
5’-Bromo-5’-deoxythymidine-3’-phosphoramidite 
(IX) and commercially available 5’-carboxy-modifier 
C10 (X, Table 1) were introduced as reactants at the 
final step of solid phase oligonucleotide synthesis. 
The synthon XI 5-[3-aminoprop-1-ynyl]-2’- 
deoxyuridine-5’-O-triphosphate was used for 
incorporating modified nucleotides into ON by using 
primer extension method while synthon IX allowed 
click-chemistry modifications (see Scheme 8). The 
synthesis of synthons IX (Table 1) was accomplished 
by following the Scheme 6 [18]. 
Synthon XI (Table 1) allowed introducing 
primary amino groups 5-(3-aminoprop-1-ynyl)- 
2’-deoxyuridine units into oligonucleotide chain and 
its synthesis was accomplished [23] by following the 
Scheme 7. 
MF-ON synthesis using post-synthetic 
modifications 
ON and their analogs were conjugated with 
appropriate fluorine-containing compounds by using 
standard approaches such as: 1) click chemistry, 2) 
activation in the presence of HBTU/HOBt, HCTU, 3) 
using activated esters such as N-hydroxysuccini-
mides, or 4) by haloacetyl reaction with thiol. The 
conjugation was achieved either immediately after 
synthesis on the column, or after purification. The 
synthesis of MF-ON 11a and 11b (Table 2) was 
achieved by using a phosphoramidite synthon IX, 
which was coupled to a 17-mer oligonucleotide using 
a solid support synthesis via a 3’- to 5’- elongation 
approach [22]. The target compounds were 
synthesized according to the Scheme 8. 
 
 
 
Scheme 5. Synthesis of synthons VIIIa starting from acylation of (S)-3-amino-1,2-propanediol. 
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Scheme 6. Synthon IX was synthesized by thymidine bromination in two steps followed by 3’-O-phosphitylation. 
 
 
Scheme 7. The synthesis of synthon XI starting from palladium-catalyzed coupling of 5-iodo-2’-deoxyuridine with an alkyne. 
 
 
Scheme 8. The synthesis of MF-ON 11a,b accomplished via a 1,3-dipolar cycloaddition involving an azido ON intermediate and propargylated ﬂuorocarbon chains. 
 
The synthesis of MF-ONs via linking 
9-[3-(perfluorooctyl)propylcarbamoyl]nonyl (FCN) 
residues was achieved [10] immediately after the 
synthesis of oligonucleotide with commercially 
available 5’-carboxy-modifier C10 (X, Table 1), which 
was introduced at the last step according to the 
Scheme 9. 
As a consequence, four different modified 
21-mer ONs with FCN groups at 5’-end were obtained 
(e.g. 1b , see Table 2). 
The synthesis of 3-(perfluorooctyl)propanoyl 
chain-conjugated peptide nucleic acids (PNA) [24] 
(compound 12, Table 2) was performed as follows: 
after the addition of the last PNA monomer, 
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Nα(Fmoc)-Nε(tBoc)-Lysine was coupled to the PNA at 
the N-terminus and further by following the Scheme 
10. 
Fluoroalkyl phthalocyanine–oligonucleotide bio-
conjugates (as example, compound 13, Table 2) were 
obtained by using solid-phase synthesis by combining 
the carboxy-derived perfluorophthalocyanine with 
5’-aminoalkyloligonucleotide-bound resin by a coup-
ling reagent HCTU: O-(1H-6-chlorobenzotriazole-1- 
yl)-1,1,3,3-tetramethyluronium hexafluorophosphate 
[25]. Synthesis of a conjugate of phosphorodiamidate 
morpholino oligonucleotides (PMO) with perfluoro 
bicyclic cell-penetrating peptide (compound 14, Table 
2) was accomplished [26] according to the Scheme 11. 
N-hydroxysuccinimides of 3,5-bis(trifluorometh-
yl) benzoates were used for the synthesis of 
oligonucleotides with 19F-labeled nucleobase [27]. 
Purified oligonucleotides with introduced 5-[3-amino 
prop-1-ynyl]-2’-deoxyuridine unit were coupled with 
N-hydroxysuccinimide ester of 3,5-bis(trifluorometh 
yl)benzoic acid or 4-[3,5-bis(trifluoromethyl)benz 
amido]benzoic acid to yield compounds 15a and 15b 
(Table 2), Scheme 12. 
Recently, the conjugation of 3,5-bis(trifluo-
romethyl)phenyl group that results in the “magneti-
cally active” oligonucleotide beacon was performed 
by linking 2-bromo-1-[3,5-di(triﬂuoromethyl)phenyl] 
ethan-1-one to hairpin oligonucleotide through the 
haloacetylation of the corresponding thiol [28] 
(Scheme 13), compound 16 (Table 2). 
Properties of oligonucleotides modified 
with MF groups 
In general, because of strong fluorous effect the 
properties of ON modified with MF groups/ 
modifiers are expected to differ from those of ONs 
bearing hydrophobic groups (e.g. acylated with fatty 
acids or derivatives of cholesterol) [22]. Those 
properties stem from the combination of the fluorous 
effect, i.e. the interaction between individual fluorine 
atoms that may result in supramolecular structures, 
and a combination of hydrophobic/lipophobic effects 
of MF groups/modifiers that may lead to an exclusion 
of those groups from water milieu. The likely 
outcome of this interaction is transient adsorption of 
supramolecular structures on hydrophobic surfaces 
which in similarity with various surfaces modified 
with hydrophobic residues [30] may result in 
transient interactions of hydrophobic domains in the 
membranes with the hydrophobic bases of ONs.  
 
Scheme 9. The synthesis of oligonucleotides with 5’-modified group as in MF-ODN 1b from properly protected ONs and linking to CPG by conjugation with 
3-(perfluorooctyl)propylamine via activated carboxy groups. 
 
Scheme 10. The final steps of compound 12 synthesis: deprotection of the ω-amino group and coupling of the resultant compound with 2H,2H,3H,3H-perfluoroundecanoic 
acid using HBTU/HOBt as a coupling reagent under microwave irradiation. 
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Scheme 11. The last step in the synthesis of compound 14: copper-catalyzed cycloaddition of specially modified PMO GCTATTACCTTAACCCAG and bicyclic peptides. 
 
Scheme 12. Final step in the synthesis of compounds 15a and 15b. 
 
Scheme 13. Synthesis of compound 16 via the reduction of corresponding disulfide followed by haloacetylation. 
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Table 2. Structure and use of fluorinated oligonucleotides. 
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Molecular models of fluorinated ODN and their synthetic mimics were performed by using MOE2016 and MOE2017 software (Chemical Computing Group, Montreal CA) 
[29]. Fluorine atoms are color coded in green. Data is available in pdb format (see Supplemental information). 
 
 
Furthermore, the lipophobic nature of MF 
modifiers may prevent the incorporation of MF 
compounds into the inner lipid core of membrane 
bilayers potentially creating defects in membranes 
that may promote MF-ON transport via model 
membranes and plasma membranes of cells. 
Consistent with such hypothesis is the observation of 
the self-assembly of MF-ON at the cellular exterior 
with the formation of resultant nanosized aggregates. 
Other non-ON amphiphilic fluorinated compounds 
were also found to form micelles that interacted with 
the surface of membranes [31]. It was hypothesized 
that such nanosized aggregates would be taken up by 
cells via energy-dependent endocytosis pathway [6]. 
It is also possible that poor miscibility between 
fluoroalkyl and phospholipids and resultant MF-ON 
exclusion from lipid membranes leads to improved 
cytotoxicity profiles [32]. The results of studies that 
used polymers containing perfluoroalkyl or semi-
fluoroalkyl groups are useful in explaining how MF 
tails help ONs to traverse lipid membrane barrier [33, 
34] (Fig. 1A). The authors established that MF chains 
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can function as anchors inducing phase separation in 
the membranes thereby causing the formation of 
defects that allow penetration of low molecular 
weight water-soluble molecules and simultaneously 
promote translocation of larger polymers through the 
membranes [34] (Figure 1B, C). Therefore, it is 
possible that unusual properties of MF-ON that drive 
aggregation and dis-aggregation of MF-ON assem-
blies are responsible for remarkable ON-membrane 
traversing process. These and other studies reporting 
the use of fluorous effect suggest that instead of direct 
incorporation of fluorine atoms into the structure of 
ON or other molecules the fluorination of carrier 
molecules can assist in more efficient delivery of 
non-modified cargo molecules into the cells. Over the 
last five years several groups successfully used 
fluorination for in vitro and in vivo delivery of native 
(i.e. non-modified) DNA expression vectors [35-37], as 
well as peptides and proteins [32, 38, 39] by using 
low-molecular weight or high-molecular weight 
branched positively charged polymeric carriers 
(reviewed in [40]). The delivery of hydrophobic low 
molecular weight compounds in vitro using 
theranostic multifluorinated nanogel carriers has also 
been recently reported [41]. It is highly likely that in 
the case of MF-ON the efficacy of multi-fluorinated 
carriers could be further improved [10]. The 
accumulated evidence regarding the fluorous effect 
on ON behavior the use of MF-ON probes and 
MF-ON based materials for probing interactions with 
various biological targets are summarized below. 
The influence of MF on stability of ON 
duplexes 
 The ability of MF-ON to form duplexes due to 
Watson-Crick base pairing can be potentially 
strengthened or, conversely, substantially weakened 
by covalent modification of individual oligonucleo-
tides forming a duplex. The MF moieties are no 
exception and the formation of duplexes was studied 
in several reports that focused on MF-ON. For exam-
ple, an introduction of a single terminal MF group has 
only a very slight influence on thermal stability (1-1.5 
degree) of the corresponding duplexes [10, 16]. An 
overall effect resulting in a decrease of MF-ON duplex 
melting temperature (Tm) with MF moiety in the 
5-position of cytosine has been reported [18]. 
GCAATCC*GGTAGCGTTAGG-CCATC, where 
C* is 5-[CF3(CF2)nCH2CH2]-C, n=1,5,7. 
The measured Tm values showed a decrease as 
the length of the MF (from 2 to 8) increased, 
suggesting that MF groups could cause interference 
with base pairing. Nonetheless, the Tm values of 
duplexes were all in the range of 53−58°C, indicating 
that stable double helix structures were formed for all 
double-stranded DNAs containing MF groups.  
The introduction of multiple MF groups into the 
composition of a 19-bp ON was shown to change Tm 
of resultant duplexes significantly, e.g. Tm of duplexes 
C3 and C6 [16] (Figure 2). In these duplexes 
postulated interaction of single MF groups on 
complementary ONs (marked by red on Figure 2) did 
not show any substantial change of Tm values 
suggesting that the stability of duplexes C2, C4 was 
similar to the duplex without MF groups, i.e. C1. 
However, Tm value determined in the case of duplex 
C3 and C6 were much higher than Tm of C1 
suggesting very strong interactions and duplex 
stabilization. The possible explanation is that the 
observed Tm increase was a result of the proximity of 
 
Figure 1. Permeation into the membranes due to “fluorous effect”. A- structures of GP and F-GP copolymers containing hydrophobic (yellow), hydrophilic (blue) and 
fluorophilic (red) building blocks. B - confocal laser scanning microscopy images of solutions containing water-soluble AlexaFluor 488 dye and 1) POPC giant unilamellar vesicles 
(GUVs) + GP (8 mM), upper row or POPC GUVs + F-GP (7.1 mM), lower row at 0 and 600 s after the injection of the GUVs in the solution of the dye and copolymer; C- 
fluorescence intensities measured within selected POPC GUVs after the addition to AlexaFluor 488 dye solution containing (A) no additive, (B) GP (8 mM) and (C) F-GP (7.1 
mM) normalized by the average fluorescence intensity of the full frame image. The numbering of the GUVs corresponds to the numbering in panel B. Adapted with permission 
from [33], copyright 2014, The Royal Society of Chemistry. 
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two MF groups on each of ON (MF-ON 6e and 6h in 
Table 2), which results in strong multiple fluorine- 
fluorine interactions. Thus, when two adjacent MF 
units were incorporated into the interior portion of 
each ON strand using synthon V (Table 1), a dramatic 
Tm increase of about 8°C followed. Importantly, if 
these two modifications within each strand are not 
adjacent (C4), the Tm increase was much less 
pronounced. The authors proposed that MF chains 
thus likely merge into a “fluorous” environment, 
avoiding unfavorable interactions with water and 
leading to significant stabilization of duplexes. If MF 
groups were positioned at the termini of the ONs 
forming the duplex, a single modification on each ON 
strand (C5) increased Tm by 2°C while an increase of 
20 °C was observed in the case of two modifications 
on each strand (C6). Such dramatic increase of Tm can 
only be explained by a formation of higher order 
structures from individual duplexes. i.e. it is possible 
that different duplex dimers (C5-C5 and C6-C6) could 
be formed after MF modification. There is a potential 
formation of “MF clips” (indicated as •) that in theory 
participate in joining individual duplexes differently, 
as shown below: 
5' TTTTTCAGTTGACCATATA-MF-3’•3’-MF- 
ATATACCAGTTGACTTTTT 5’ 
3’ AAAAAGTCAACTGGTATAT-MF-5’•5’-MF- 
TATATGGTCAACTGAAAAA 3’ 
5'TTTTTCAGTTGACCATATA-MF-MF-3’•5’MF
-MF-TATATGGTCAACTGAAAAA 3'  
3’AAAAAGTCAACTGGTATAT-MF-MF-5’•3’
MF-MF-ATATACCAGTTGACTTTTT 5’ 
C6•C6 MF-ON dimer may potentially exhibit 
properties of a pseudo continuous 38-mer. By using 
available on-line resource it is easy to estimate that Tm 
of a non-modified 38-mer ON with the same sequence 
as two C6 will be higher than Tm of 19-mer ON duplex 
by approximately 20 degrees [42]. Thus, it appears 
that fluorous effect due to multiple MF moieties 
introduced by using synthon V or a branched synthon 
IV (Table 1) could provide DNA duplex stability 
increase across the range of temperatures, and might 
be useful for assembly of various supramolecular 
structures from individual duplexes. 
MF-ON as imaging and spectroscopic probes 
It is commonly assumed that both NMR 
spectroscopy and MRI could take advantage a 
negligible 19F background signal due to the fact that 
soluble molecules containing fluorine atoms in living 
organisms are present at very low concentrations and 
that the great majority of those are technogenic. 
Moreover, the wide chemical shift range of various 19F 
nuclei is also advantageous in that it enables the 
design of various sensors and facilitates imaging of 
several molecular species at once [43]. The 
incorporation of single fluorines in nucleic acids has 
been used for decades for the purpose of structural 
studies involving nucleic acids interactions cognate 
biological targets such as complementary ON and 
DNA-binding proteins [43-45]. In the case of MF-ON 
probes the presence of multiple fluorines improves 
sensitivity and provides unique spectroscopic 
signatures. For example, using the nucleoside synthon 
VIII (Тable 1) as a precursor of an NMR reporter 
nucleoside [17] MF-ONs containing perfluorinated 
tert-butyl group (nine magnetically equivalent 
fluorine atoms total per molecule) were synthesized 
and used for spectroscopic monitoring of a duplex 
formation to investigate the transition from single 
strand to duplex achieving micromolar sensitivity to 
ONs. The incorporation of multiple magnetically 
equivalent fluorine atoms into the ON’s composition 
resulted in a chemical shift of -67.36 ppm (relative to 
CCl3F) in a single-strand ON, and with the addition of 
the complementary strand a new peak at -66.91 ppm 
was observed, which signified the formation of the 
ON duplex [17] (Figure 3A). A sensor DNA molecule 
with stem-loop configuration that was tuned to 
interaction with a complementary ON by 19F MR 
signal was proposed in [20]. The probe was based on 
the paramagnetic relaxation enhancement (PRE) effect 
due to interaction with Gd-DOTA chelate linked to 
the 3’-terminus of the ON probe. The resultant 
molecular beacon carrying bis(trifluoromethyl)-
benzene moiety on the 5’-end was able to report on a 
formation of a duplex with target nucleic acid as a 
result of 19F MR signal “turn-on” with sequence 
specificity as demonstrated in the case of synthetic 
Kras ON sequence carrying mutations [20] (Figure 
3B). A similar design of “responsive” 19F hairpin-like 
probe containing modifications at both of the termini 
of the hairpin has been recently reported in which the 
fluorinated group served as a reporter [28]. The 
magnetically equivalent fluorine atoms (a result of a 
modification of the ON’s terminal thiol with a MF 
residue) served as reporters similar to the design of 
the beacon initially suggested in [17]. When this 
hairpin was not bound to the complementary target 
the authors observed a broadened 19F NMR peak 
(turned “off”) due to PRE effect of the nitroxide 
radical. The 19F NMR peak of the beacon was 
“recovered” in the event of beacon ON sequence 
hybridization to a complementary ON due to physical 
separation from the nitroxyl radical [28]. Therefore, in 
addition to widely-used fluorescent labeled ON 
beacons PRE-effect based probes may be potentially 
used for detecting complementary ON structures as well 
as sequence mismatches. If the delivery of excitation 
light becomes a problem because of the turbidity of 
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the medium then MR spectroscopy and imaging 
become attractive alternative to fluorescent imaging. 
 
 
Figure 2. Representative melting temperature curves of MF-containing DNA 19-mer 
duplexes. Red spheres represent the MF- modification. Left: Internal modifications. 
Right: External modifications. Adapted with permission from [16], copyright 2016 
The Royal Society of Chemistry. 
 
The ability of MF-ON to form nanoparticles 
The behavior of MF-ON in water solutions 
depends on the following factors: 1) the structure of 
MF component, 2) the chemical nature of ON segment 
(i.e. whether ON is comprised of DNA, RNA, ON 
analogs like PNA, PMO or their combinations), 3) the 
length of ON, 4) the net charge, 5) media components 
(i.e. ionic strength, temperature, the presence of 
cations of bivalent metals). The assembly properties of 
MF-ON with particular single or multiple MF groups 
was previously reported in some detail in [16]. In that 
study, MF groups were introduced into 
oligonucleotide chains or their termini by using 
synthon V (Table 1). The examples of the structure of 
several ONs and their duplexes are shown in Table 2 
(MF-ON 6a-6h). MF-ON 6a with just one single 
terminal perfluorooctyl MF group does not 
self-associate and form micelles in water even after 
the addition of magnesium cations (Mg2+) while 
MF-ON 6b does not aggregate in pure water but the 
addition of Mg2+ triggers self-assembly into 
nanoparticles. Upon the addition of Mg2+, MF-ON 6c 
forms micelles with 4 or 5 MF-ON monomeric units, 
which undergo a significant radius decrease within 
one minute after adding (from approximately 8 nm to 
6 nm). Mg2+ likely cause neutralization while assisting 
in formation of salt bridges between the negatively 
 
 
Figure 3. A - a nucleoside carrying a tert-butyl MF group that was incorporated in ODN. Transition from single strand to duplex was monitored by 19F NMR spectroscopy at 
micromolar concentrations of oligomers that showed a chemical shift change (∆δ), demonstrating the sensitivity as an NMR reporter nucleoside, adapted with permission from 
[17], copyright 2008, American Chemical Society; B- a schematic drawing of the mechanism of target nucleic acid detection using stem-loop typed oligonucleotide probe with 
incorporated MF group and Gd-DOTA at the opposite termini of the probe. 19F NMR spectra and signal intensity of the probe in the presence of various oligonucleotides. (a) 
Probe alone; (b) + Kras Mut; the arrow points to 19F NMR signals of the bis(trifluoromethyl)benzene moiety. Adapted with permission from [20], copyright 2019 Elsevier B.V. 
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charged ON phosphates. The resultant decrease of the 
repulsive electronegative interactions between the 
ON DNA strands and MF components promotes the 
self-assembly into nanoparticles. The analysis of such 
micelles by using denaturing polyacrylamide gel 
electrophoresis in 7 M urea showed that in ON with 
four and five MF moieties very strong self-assembly 
interactions occur and the resultant material is not 
able to penetrate into the gel matrix. In a similar study 
it has been demonstrated that an ON with terminal 
4-(bis[3-(perfluorooctyl)propyl]amino)phenyl groups 
(MF-ON 5a, Table 2) promote a spontaneous 
self-assembly into the micelle-like structures [15] 
(Figure 4). The addition of acetone (v/v = 1:1) resulted 
in the dissociation of those micelle-like structures. The 
elongation of oligothymidine chain from n=15 to n=45 
diminished the stability of micelles. The hydro-
dynamic diameter of micelles in PBS was 57.8 nm 
with a polydispersity index of 0.382 as measured by 
DLS. However, the visualization of morphology by 
using atomic force microscopy showed a layer of 
uniform spherical particles with smaller diameters of 
22.9 ± 3.4 nm. The linking of MF groups to PNAs leads 
to the formation of smaller size nanoparticles (100–250 
nm) from control non-fluorinated (C11-hydrocarbon 
undecanoyl)-PNAs compared to the larger size 
nanoparticles (500 nm), which according to the 
authors may improve the efficiency of PNA 
penetration into the cells [24]. 
Therefore, as follows from several reports 
published so far the MF moiety does impart a 
tendency to promote self-assembly of MF-ON into 
micelle-like structures. If the goal of fluorination is in 
improving delivery into the cells it appears important 
to identify each particular oligonucleotide with the 
corresponding MF modification that facilitates the 
crossing of the membrane barrier while avoiding the 
formation of very stable self-associated micelles that 
would not permeate into or dissociate within the cells. 
The stability of MF-ON against 
nuclease-mediated hydrolysis 
Multifluorinated groups can potentially provide 
additional benefit of increasing stability to DNA 
hydrolysis by nucleases due to the protein-repelling 
properties of MF group that are able to protect short 
non-modified (native) siRNA-based duplexes from 
degradation by linking those MF groups to carrier 
molecules [46]. However, for increasing stability MF- 
modifications may be introduced into the ONs 
directly thereby eliminating the need in carrier 
molecules. To compare the stability of MF-containing 
and control duplexes, a non-modified 19-mer duplex 
and MF-ON conjugates C1-6 (Figure 2) were exposed 
to fetal bovine serum (FBS) at 37°C [16]. As a result, 
C2 duplex with a single MF group on each ON 
showed better nuclease resistance than duplex C1. 
Interestingly, two adjacent modifications enhanced 
the half-life of the duplex in FBS by a factor of 3. With 
two modifications at the end of each DNA strand, C6 
showed impressive nuclease resistance properties 
since approximately 50% of the initially detected ON 
were still present after 24 h incubation in contrast to 
 
 
Figure 4. A - Bis(perfluorooctylpropyl)−DNA Micelle (PFDM) containing a hydrophobic perfluorocarbon core and a hydrophilic oligonucleotide corona. B- dynamic light 
scattering (DLS) of the self-assembled PF−T15 micelles; C - atomic force microscopy of self-assembled PF−T15 micelles on a mica surface; D - HeLa cells treated with 
TAMRA-labeled PFDM (200 nM) and subsequently examined by confocal microscopy. Adapted with permission from [15], copyright 2018, American Chemical Society. 
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only 3% in the case of C1. Thus, perfluorocarbon 
modifications could increase DNA stability very 
significantly and simultaneously improve the 
resistance to nucleases. 
A different design containing ON duplex 
elements, i.e. molecular beacons with multiple 
terminally linked F-bases were also tested in nuclease 
stabilization assays [19]. It was shown that these 
beacons have increased stability due to the fact that 
fluorinated base pairs cannot be recognized by 
endonucleases (Figure 5A,B). Consequently, the 
replacement of natural base pairs by F-bases pairs 
makes modified ON more resistant to degradation. 
Therefore, it is potentially possible that the formation 
of the micelle-like structure could improve the 
stability of DNA molecules [15]. 
Previously reported near-infrared fluorescent 
ON duplexes were modified by one or two MF groups 
at 5’-ends by using 3-(perfluorooctyl)propyl residues 
[10]. These duplexes were designed as imaging probes 
for STAT3 binding for deep tissue imaging. The 
modification was achieved by using the synthon Ia 
(Table 1) [10]. The stability of four obtained ON 
duplexes: 
     Cy3 
5’ -AGCC|ATTTCCCGTAAATCTCT-3’ 
3’- TCGGTAAAGGG|CATTTAGAGA-5’ 
 
                               Cy3 
5’-CF3(CF2)7(CH2)3pAGCC|ATTTCCCGTAAATCTCT-3’ 
3’-TCGGTAAAGGG|CATTTAGAGAp(CH2)3(CF2)7CF3-5’ 
 
5’-CF3(CF2)7(CH2)3pAGCCAT|TTCCCGTAAATCTCT-3’ 
3’-TCGGTAAAGGG|CATTTAGAGAp(CH2)3(CF2)7CF3-5’ 
                           Cy3 
 
5’-AGCC|ATTTCCCGTAAATCTCT-3’ 
3’-TCGGTAAAGGG|CATTTAGAGAp(CH2)3(CF2)7CF3-5’  
                      Cy3 
 
in the presence cell culture-conditioned medium was 
analyzed by using agarose electrophoresis (see 
examples in Figure 5C). All four duplexes were 
binding to medium components regardless of the 
presence of MF groups. After incubating samples at 
37oC it has been determined that all MF-ON and 
control ON duplexes showed at least some degree of 
degradation and association with the cell culture 
media proteins (between 7.5% and 12% of total ON). 
 
 
Figure 5. Stability of MF-ODN. A- fluorescence intensity kinetics of F6 MB (a molecular beacon carrying six F-base pairs) treated with complementary DNA B- fluorescence 
intensity change over time in the solutions of F6 MB (red trace) and N6 MB (black trace) after treating with 0.25 U/mL DNase I, adapted with permission [19] copyright 2017, 
The Royal Society of Chemistry; C- a scheme showing major structural elements of fluorescent, Cy3-labeled oligonucleotide duplexes (ODND), containing either one 5’-linked 
perfluorooctylpropyl group (1FO-ODND-Cy3) or two FO groups (2FO-ODND-Cy3). Fluorinated residues are shown in bright green, Cy3 fluorophore is shown in magenta. 
Yellow - phosphorothioates in hybrid (PS) ODNs; D- quantification of intact and degraded fractions of ODND as determined by using ROI measurements of integrated band 
intensity after gel electrophoresis on 15% polyacrylamide gel stained with SybrGold, adapted with permission from [10], copyright 2017, Ivyspring International Publisher. 
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After incubation the degradation was at the level of 
33-35% for MF-containing ON with three 
phosphorothioate bonds (Figure 5 C, D) at each 
terminus. In the absence of MF groups the 
degradation of ON exceeded 50%, which indicated at 
least some protective effect of MF groups in the case 
of a mix of nucleases in the cell culture medium.  
Permeation of MF-ON and their analogs into 
eukaryotic cells and lysosomal escape 
It has been reported that ON and their synthetic 
analogs such as locked nucleic acids modified with 
phosphorothioates (i.e. gap-mers) could be delivered 
into the eukaryotic cells in the absence of any 
transfection reagents via mammalian ortholog of 
SID-1 proteins (SIDT-2) due to the process called 
gymnosis [47, 48]. At present it is unclear whether 
gymnosis is involved in transmembrane transport of 
MF-ON bearing bulky fluorinated groups. However, 
the consequences of fluorine-fluorine interactions 
may include the formation of supramolecular 
structures and particle compaction which may 
facilitate cellular internalization of these 
fluorine-containing particles [22, 24]. The efficient 
uptake in the absence of transfection-promoting 
agents usually requires either lipid or fluorinated 
chain conjugation to the ONs. Initial experiments with 
MF-ON have shown that similarly to hydrocarbon–
conjugated ON (L-ON) the linking of MF groups 
improves intracellular uptake of nucleic acids. The 
observed toxicity to cells of MF-ON was negligible 
and cellular internalization of MF-ON without any 
transfecting reagents was efficient and was not 
affected by the presence of serum [22].  
Unlike classic ONs fluorescent-labeled PNAs 
modified with a single perfluoroundecanoyl chain 
showed 2.5 -3 times higher uptake efficiency in NIH 
3T3 and HeLa cells compared to their 
hydrocarbon-modified undecanoyl PNA counterparts 
[24, 49]. Strong 10-fold increase of mean fluorescence 
intensity was noted and 2- times (HeLa) and 3-times 
(3T3 cells) higher number of fluorescent cells were 
detected in the case of MF-PNA compared to 
hydrocarbon-modified PNA. Similarly to the results 
reported in [16], the linking of perfluorinated moieties 
to PNAs resulted in the formation of smaller size 
nanoparticles (2-times, mean diameter- 250 nm) 
compared to larger size nanoparticles formed by 
non-fluorinated PNAs. This may explain better 
efficiency of cell uptake and/or trans-membrane 
transport and these results may provide a rationale 
for engineering PNAs with improved cell delivery 
properties. 
The incorporation of MF-ON micelle 
components into cell membranes was investigated in 
[15]. The components of those micelles included 
MF-ONs synthesized by using a branched MF 
-synthon IV (Table 1) while the opposite terminus of 
ON carried a pH-insensitive rhodamine dye 
(TAMRA) to avoid the influence of cellular 
compartments with altered pH environments. T 
lymphoblast-like cells (CCRF line) were subjected to a 
short-term incubation in the presence of 
TAMRA-labeled MF-ON or TAMRA-labeled control 
ON. Flow cytometry of cells showed large TAMRA 
ﬂuorescence intensity shift (137 times) of the cells 
treated with MF-ON while only minimal ﬂuorescence 
signal was detected in the cells treated with MF- free 
ON probes. This result was explained by the effect of 
introducing a MF group that greatly facilitated the 
interaction of DNA macromolecules with live cells. 
The intracellular location of MF-ON was determined 
by using confocal microscopy which showed that 
MF-ON treatment resulted in a bright TAMRA signal 
localized on the surface of the cells. TAMRA-labeled 
MF-ON was also anchoring at the membrane of 
adherent HeLa cells. The authors speculate that ON 
micellar structures tend to dissociate and the 
monomeric MF-modified units undergo a 
spontaneous insertion into the plasma membrane due 
to local alterations of hydrophobic interactions within 
the membrane. Сysteine arylation chemistry was used 
to introduce multiple fluorinated groups into 
arginine-rich peptide conjugated to PMO to modulate 
their ability to induce exon skipping in reporter HeLa 
cell line where ON analogs corrected EGFP splicing 
and restored fluorescence of the reporter gene [26]. 
These bicyclic peptides exhibited substantial protease 
resistance and did not display signs of cytotoxicity in 
cell culture even at high concentrations in the 
millimolar range. The perfluoroaryl cyclic and bicyclic 
peptides improved MF-ON analog exon-skipping 
activity approximately 14-fold over the unconjugated 
ON analogs. The bicyclic peptides exhibited increased 
proteolytic stability relative to the monocycle 
demonstrating that perfluoroaryl bicyclic 
arginine-rich peptides have a potential as potent and 
stable delivery vehicles of ON analogs. Cell culture 
uptake was also studied in detail by using various ON 
duplexes covalently labeled with Cy3-dye via 
internucleoside amino linkers (Figure 5C). These 
duplexes carried one or two MF groups (i.e. PS, 
1PF-PS, 2FO-PO and 2PF-PS ON duplexes) [10]. The 
uptake experiments demonstrated that the 
MF-modified ON underwent efficient internalization 
into A431 and INS-1 cells and that the uptake of the 
ON modified with MF groups was much more 
efficient than control ON that carried no MF groups. 
Mean fluorescence intensity measured in the 
cytoplasm of INS-1 using segmentation of 
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fluorescence intensity images showed that INS-1 cell 
fluorescence was on the average 3-times higher in the 
case of MF-modified 2PF-PS ON duplex than PS ON 
duplex (Figure 6). The hybrid PO/PS ON duplexes 
were taken up by A431 cells much more efficiently 
that by INS-1 cells. The linking of additional MF 
residues to ON duplexes resulted in statistically 
significant increase of intracellular fluorescence 
reflecting the enhanced efficacy of uptake. ON 
carrying two MF groups (2PF-PS) showed 
considerably higher (at least 5-times) uptake in A431 
cells compared to the PS control. 
Several independent reports suggested that 
introduction of a single or multiple MF groups could 
help ON to escape lysosomal uptake. In particular, as 
indicated by LysoTracker green staining only a 
minimal TAMRA ﬂuorescence signal was co-localized 
in the lysosomes of cells in the case of branched 
MF-ON [15] potentially suggesting that MF-ON 
molecules were either escaping from the lysosomal 
compartment after endocytosis, or that they were not 
subject to endocytosis and penetrated cells via an 
alternative pathway. The observed low levels of 
lysosomal sequestration are in agreement with the 
results of previous reports which indicated that 
ﬂuorinated chains facilitate lysosomal escape of 
nanoparticles or their components [50]. Since 
lysosomes contain various hydrolases, which cause 
rapid digestion of various biomolecules the observed 
lysosomal escape is advantageous for applications of 
therapeutic oligonucleotides and their analogs in gene 
editing and gene therapy. 
Cytotoxicity of MF-ON and their analogs 
Most of the reports on MF-ON use in cell culture 
published so far lack systematic cytotoxicity studies. 
However, there is an agreement on low acute 
(short-term) cytotoxicity of oligonucleotides and their 
analogs carrying MF groups. For example, cytotoxic-
city of PMO [26] and MF-ON [22] was evaluated by 
assessing cell viability after incubation for 5 days in 
Huh7 cells with increasing concentrations of MF-ON. 
Both reports mention the lack of cytotoxicity at high 
concentrations (up to 2 μM).  
 
 
 
Figure 6. Confocal microscopy and quantification of cellular uptake of the MF-modified ON duplexes. Cy3-labeled ON duplexes (0.5 µM) modified with 5’-linked MF groups 
were incubated for 18 with the cells. A, B – confocal multichannel fluorescence microscopy of insulinoma INS-1 cells after an overnight incubation with PS-Cy3 (A) or 
1PF-PS-Cy3 (B) ON duplexes. D,E- confocal microscopy of human squamous cell carcinoma A431 cells after incubating with 1PF-PS-Cy3 (D) or 2PF-PS-Cy3 (E). Blue channel: 
DAPI. Green channel: anti-EGFR-AF488 (A431 cells) or AF488-NHS (INS-1). Red – Cy3 (ON). C, F – quantification of the uptake using mean fluorescence intensity of Cy3 in 
individual cells (C- INS-1; F- A431). Column statistics and P values were determined by using non-parametric Mann-Whitney test, n=30-60 cells. Adapted with permission from 
[10], copyright 2017, Ivyspring International Publisher. 
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The effect of MF groups on protein recognition 
by ON duplexes 
A variety of ONs are designed so they could 
engage in nucleic acid-protein interaction in 
intracellular environment. These interactions are 
essential for CRISPR-cas9 gene editing, proper 
processing of RNAi components and for achieving 
transcription factor inhibition by ON duplex decoys 
[50-52].The effect of MF on the specificity ON duplex 
decoy binding to STAT3 transcription factor binding 
was studied by us in A431 cells [10]. The duplex 
containing STAT3-recognition GAS sequence was 
labeled with near-infrared NIR Dye 800CW by using 
an internucleoside amino linker. As a consequence, a 
low background was observed facilitating high 
sensitivity fluorescent detection of ON duplex 
binding with STAT3 by using electrophoretic shift 
mobility assay. The assay showed that all 
phosphorothioate-modified ON duplexes devoid of 
MF groups and a control commercially available 
near-infrared ON probe showed similar patterns of 
electrophoretic mobility shift in the presence of A431 
nuclear lysates. The addition of an excess of the 
non-labeled duplex probe resulted in the elimination 
of the band corresponding to a complex with STAT3, 
which allowed determining of the specificity of 
duplex-STAT3 binding. The addition of anti-STAT3 
antibody to the mixture resulted in detectable 
supershift. The introduction of a single MF group 
resulted in an increase of duplex binding specificity as 
the intensity of a non-specific band decreased in 
intensity, while MF- modified duplex was still able to 
recognize STAT3. However, unlike non-modified 
duplex and the duplex carrying a single MF-group, 
the linking of two MF groups to opposite termini of 
the duplex resulted in a loss of binding to either 
STAT3, or to unrelated components in the lysate.  
Comparison of multifluorinated and 
lipid-modified oligonucleotide 
conjugates 
There are multiple similarities between the 
properties of ON modified by “traditional” 
hydrophobic groups (such as various lipids) and 
MF-ON since both types of modifications have a 
tendency to promote the formation of supramolecular 
structures and to improve internalization in the cells. 
In both cases by introducing relatively short lipophilic 
or multifluorinated groups it is possible to 
dramatically change the properties of ON despite the 
fact that those groups are usually relatively small in 
size compared to the hydrophilic 20-25 bases-long 
oligonucleotide chain (or equivalent number of base 
pairs in the case of ON duplexes) [53]. The examples 
of direct comparison between MF-ON and L-ON in 
parallel experiments are very few and while 
MF-modified PNA (perfluoroundecanoyl groups) 
showed more efficient uptake than lipid-modified 
PNA (2-3 time more PNA-positive cells) [24, 49], ON 
modified with short MF (perfluorohexyl and 
perfluorooctyl) groups were taken up by the cells less 
efficiently than L-ON [22]. The authors compared 
intracellular uptake at 37oC of either 3’-fluorescein- 
labelled perfluorooctyl-, perfluorohexyl- modified 
ON, or unconjugated ON in the culture of three 
human cell lines (hepatic Huh7, gastric epithelial 
NCI-N87 and embryonic kidney HEK293). Similar to 
the case of hydrocarbon-modified L-ON, 
perfluorooctyl-ON were internalized at similar rates 
by all cells in all three cell lines, whereas 
unconjugated ONs did not penetrate into the cells 
under the chosen experimental conditions. 
Perfluorohexyl-ON was internalized less efficiently, 
indicating that the structure of MF group was 
important for the cellular internalization. To evaluate 
the internalization kinetics of MF-ON, Huh7 cells 
were incubated in the presence of 0.5 μM of MF-ON, 
L-ON or unconjugated ONs for either 4 or 24 h. L-ON 
were internalized more rapidly than both MF-ON 
with almost 100% of cells showed specific 
fluorescence after 4 h of incubation, whereas only 20% 
and 40% cells were fluorescent in the case of 
perfluorohexyl and perfluorooctyl ON, respectively. 
The cell uptake of both perfluorooctyl and 
perfluorohexyl ON was dramatically decreased at 
4oC, which suggested that similarly to lipid-modified 
ON, MF-ON enter the cells via energy-dependent 
mechanisms (such as endocytosis or gymnosis) rather 
than a result of passive transition into the membrane. 
Unlike MF-ON, which remain at the early phase of 
development, L-ON were known for decades and 
were actively investigated for drug delivery purposes. 
Some of the lessons learned during the development 
of L-ON as pharmaceuticals may be highly relevant to 
the case of MF-ON. For example, it is known that 
L-ON interact with lipoproteins or hydrophobic 
surfaces resulting in substantial changes of their 
pharmacokinetic behavior and trans-membrane 
delivery [54, 55]. In biological environments two 
competing processes, i.e. the self-assembly of L-ON 
into supramolecular structures (aggregation) and the 
ability to undergo insertion into membranes 
(resulting in dis-aggregation) should always be taken 
into account to understand and interpret their 
behavior [53]. It is known that many highly-efficient 
phosphorothioate- stabilized ON may enter cells by 
multiple and interchangeable pathways which does 
not require the involvement of clathrin- and caveolin- 
dependent mechanisms (i.e. receptor-mediated 
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endocytosis) [56]. However, lipophilic groups appear 
to be re-directing L-ON toward the receptor-mediated 
endocytosis. The efficiency of endocytosis depends 
greatly on the structure of particular L-ON [53, 57]. 
For example, double-tail lipid modification resulted in 
a higher degree of incorporation into both lipid model 
membranes and plasma membranes of the cells [57]. 
Lipid groups linked to the termini of an ON do not 
result in major changes in the ability of lipid-modified 
ON to interact with a complementary strand since the 
observed change in melting of resultant duplexes 
does not exceed 2ºC, whereas dual modifications by 
using lipids located across from each other on 
complementary strands may result in stabilizing the 
resultant duplex by up to 29ºC [55, 58]. Several 
seminal reports showed that efficient and selective 
uptake of L-ON (e.g. in the case of lipid-siRNA) 
depended on interactions with lipoprotein particles, 
lipoprotein receptors and transmembrane proteins 
[59, 60], i.e. that hydrophobicity is the primary force 
driving the systemic distribution of short ON 
duplexes such as lipid-conjugated siRNAs via lipid 
transport [60, 61]. Recently, various modifications of 
siRNA were compared in terms of the effects on 
biodistribution after various lipid moieties (saturated 
and unsaturated fatty acids, steroids and vitamins) 
were conjugated and accumulation levels of these 
compounds were compared in various tissues (such 
as liver, spleen, and pancreas [61]). The main 
conclusion of this study was that lipid conjugates 
support much broader delivery of siRNAs and enable 
functional silencing of target genes in many tissues, 
including liver, kidney, lung, heart, muscle, spleen, fat 
and adrenal glands. Lipid conjugate engineering can 
enhance extra-hepatic delivery and expand the 
therapeutic potential of siRNAs beyond major organs 
of reticuloendothelial system. An important 
advantage of lipid-conjugation is that its impact on 
biodistribution is sequence-independent [61] which 
broadens the potential scope of applications in vivo. 
The same appears to be true in the case of MF 
modifications. However, making parallel 
comparisons between potential effects of MF and L 
modifiers is not always feasible due to obvious 
paucity of experimental data. 
Conclusions and future perspectives 
The experiments performed so far with the 
MF-ON (either with single ON, or ON duplexes) and 
their analogs carrying either one or two fluorinated 
“tails” show multiple drastic changes of ON behavior 
in situ and in vitro including the improvement of 
stability against degradation. Multiple reports concur 
on the effects of MF modifications that result in a 
significantly higher uptake in the cells over time in 
vitro. Compared to control nonfluorinated ON, 
MF-ON usually preserves biological activity. The 
accumulated evidence indicates the high potential of 
probes, RNAi components and beacons based on 
MF-ON for improving intracellular delivery of ONs in 
vitro and in vivo. Continuously evolving structural 
designs and improved synthon chemistry enable the 
development of the next generation of MF-ON, which 
likely will be based on ON with branched and split 
multifluoroalkyl tails. These designs may potentially 
mitigate the concerns associated with the persistence 
of perfluorinated acids in various environments since 
such newer generation of MF-ON will be a subject to 
biodegradation and easier excretion as some of the 
designs of MF-ON already suggest [62]. The possible 
candidates could potentially include branched 
designs containing nonafluoro-tert-butyl group that 
increases fluorous effect almost as efficiently as 
C8F17(CH2)3 [62] or recently published 
C6F13-containing “split tails” (see [63] and references 
therein).  
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